← Back to Search

Virtual Reality Gaming for HIV-Related Health Prevention (LEARN Trial)

N/A

Recruiting

Led By S. Raquel Ramos, PhD, MBA, MSN, FNP-BC

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

No medical history of serious cardiovascular or cognitive complications

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and month 3 & 6

Awards & highlights

LEARN Trial Summary

This trial is testing a virtual reality environment to see if it can help prevent HIV-related health problems.

Who is the study for?

This trial is for gay, same-gender-loving, or MSM individuals who are ethnic/racial minorities with HIV. Participants must understand English and have a computer to run the virtual environment software. They should not have had serious heart or brain events or cognitive impairments.Check my eligibility

What is being tested?

The study tests a virtual gaming environment aimed at preventing cardiovascular diseases in people living with HIV. It explores whether this innovative approach can improve health outcomes compared to traditional methods.See study design

What are the potential side effects?

Since the intervention involves gaming in a virtual environment, potential side effects may include eye strain, headaches, dizziness, or motion sickness from prolonged screen time.

LEARN Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have no history of serious heart or brain health issues.

LEARN Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and month 3 & 6

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and month 3 & 6

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and month 3 & 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability/Feasibility {change over 3 timepoints}

Secondary outcome measures

Cardiovascular health {change over 3 timepoints}

Food consumption {change over 3 timepoints}

Illness Perceptions {change over 3 timepoints}

+3 more

LEARN Trial Design

2Treatment groups

Experimental Treatment

Group I: Waitlist Control GroupExperimental Treatment1 Intervention

Participants will enter an online game at a later date after the immediate intervention group and learn about how to prevent cardiovascular and metabolic conditions.

Group II: Immediate Intervention GroupExperimental Treatment1 Intervention

Participants will enter an online game and learn about how to prevent cardiovascular and metabolic conditions.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH

3,837 Previous Clinical Trials

47,851,514 Total Patients Enrolled

Yale UniversityLead Sponsor

1,852 Previous Clinical Trials

2,738,361 Total Patients Enrolled

S. Raquel Ramos, PhD, MBA, MSN, FNP-BCPrincipal InvestigatorYale University School of Nursing

1 Previous Clinical Trials

322 Total Patients Enrolled

Media Library

Gaming in a virtual environment Clinical Trial Eligibility Overview. Trial Name: NCT05242952 — N/A

Cardiovascular Disease Research Study Groups: Waitlist Control Group, Immediate Intervention Group

Cardiovascular Disease Clinical Trial 2023: Gaming in a virtual environment Highlights & Side Effects. Trial Name: NCT05242952 — N/A

Gaming in a virtual environment 2023 Treatment Timeline for Medical Study. Trial Name: NCT05242952 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who is the ideal subject for this medical study?

"This study is seeking 80 individuals aged 30 to 65 who possess cardiovascular diseases and meet certain demographics. These persons should identify as a minority with HIV, have no serious historical medical conditions related to the heart or brain, be able to read English, identify as gay/same-gender-loving/MSM, and own an operational computer suitable for downloading VE software."

Answered by AI

Are enrollment opportunities still available for eligible candidates in this trial?

"Affirmative. Clinicaltrials.gov data demonstrates that the medical trial, which was initially advertised on November 15th 2022, is currently enrolling patients. Approximately 80 individuals are sought to participate at one particular site."

Answered by AI

What is the total number of participants in this research project?

"Affirmative. Clinicaltrials.gov data verifies that recruitment is ongoing for this medical trial, which was initially posted on November 15th 2022. As of October 5th 2022, 80 individuals are required to participate at one site."

Answered by AI

Is this experimentation open to those aged 50 and over?

"Per the specified inclusion criteria, eligible participants must be aged between 30 and 65. Additionally, there are 27 studies for minors below 18 years old and 369 trials catering to seniors over 65."

Answered by AI

Recent research and studies

Journal of the Association of Nurses in AIDS CareJournal

Purely Behavioral: A Scoping Review of Nonpharmacological Behavioral and Lifestyle Interventions to Prevent Cardiovascular Disease in Persons Living with HIV

Ramos, S. Raquel, Olivia M. O'Hare, Ailene Hernandez Colon, Susan Kaplan Jacobs, Brynne Campbell, Trace Kershaw, Allison Vorderstrasse, and Harmony R. Reynolds. 2021. “Purely Behavioral: A Scoping Review of Nonpharmacological Behavioral and Lifestyle Interventions to Prevent Cardiovascular Disease in Persons Living with HIV”. Journal of the Association of Nurses in AIDS Care. Ovid Technologies (Wolters Kluwer Health). doi:10.1097/jnc.0000000000000230.

Behavioral MedicineJournal

A Framework for Using Ehealth Interventions to Overcome Medical Mistrust Among Sexual Minority Men of Color Living with Chronic Conditions

Ramos, S. Raquel, Rueben Warren, Michele Shedlin, Gail Melkus, Trace Kershaw, and Allison Vorderstrasse. 2019. “A Framework for Using Ehealth Interventions to Overcome Medical Mistrust Among Sexual Minority Men of Color Living with Chronic Conditions”. Behavioral Medicine. Informa UK Limited. doi:10.1080/08964289.2019.1570074.

JMIR Research ProtocolsJournal

Cardiovascular Disease Prevention Education Using a Virtual Environment in Sexual-minority Men of Color with HIV: Protocol for a Sequential, Mixed Method, Waitlist Randomized Controlled Trial

Ramos, S Raquel, Constance Johnson, Gail Melkus, Trace Kershaw, Marya Gwadz, Harmony Reynolds, and Allison Vorderstrasse. 2022. “Cardiovascular Disease Prevention Education Using a Virtual Environment in Sexual-minority Men of Color with HIV: Protocol for a Sequential, Mixed Method, Waitlist Randomized Controlled Trial”. JMIR Research Protocols. JMIR Publications Inc.. doi:10.2196/38348.

clinicaltrials.govStudy